Financials
Financial year 2025
INNOVATIVE MEDICAL SOLUTIONS HOLDING from Bilzen-Hoeselt, company number BE0547890444, closed financial year 2025 with a result of € 68,345 after tax. For that financial year INNOVATIVE MEDICAL SOLUTIONS HOLDING recorded revenue of € 991,623 and equity of € 2.4 million. Compared with financial year 2024, the result moved from € 65,483 to € 68,345. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 9, 2026.
€ 2.4 million
▲ 3% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 68,345
▲ 4% vs 2024
Profit after tax over the fiscal year.
€ 11,759
▲ 70% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 2.2 million.
People and assets in 2025
0.8
Average over the fiscal year, from the social balance sheet.
€ 59,648
▼ 39% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 10,180
Loans from banks and other lenders, long and short.
€ 72,181
▼ 10% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 31 days on average.
€ 6,494
▼ 42% vs 2024
Wages, holiday pay and social contributions still to pay. No outstanding taxes.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 1,014,144 | € 1,171,715 | € 1,041,941 | € 991,623 | ▼ 5% |
| Profit after taxes | € 846,774 | € 79,002 | € 65,483 | € 68,345 | ▲ 4% |
| Equity | € 2,152,014 | € 2,231,016 | € 2,296,499 | € 2,364,844 | ▲ 3% |
| Total debts | € 130,956 | € 256,722 | € 101,402 | € 88,854 | ▼ 12% |
| Cash | € 8,629 | € 4,779 | € 6,934 | € 11,759 | ▲ 70% |
| Retained profit | € 1,979,285 | € 2,058,287 | € 2,123,770 | € 2,192,115 | ▲ 3% |
| Bank debt | € 10,037 | € 10,147 | € 10,151 | € 10,180 | |
| Balance sheet total | € 2,282,970 | € 2,487,738 | € 2,397,901 | € 2,453,698 | ▲ 2% |
| Employees (FTE) | 1.8 | 1.6 | 0.8 | 0.8 |
Key figures of INNOVATIVE MEDICAL SOLUTIONS HOLDING, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to INNOVATIVE MEDICAL SOLUTIONS HOLDING?
What happened at INNOVATIVE MEDICAL SOLUTIONS HOLDING in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 68,345 (▲ 4% vs 2024). Source: NBB ↗
- Margaretha van den Broek became a director. NBB
- Bart de Bresser became a director. NBB
- New establishment in Bilzen-Hoeselt. KBO
- Start of the company according to the CBE. KBO
In short
From € 846,774 profit in 2022 to € 68,345 profit in 2025.
Paid € 98,303 in corporate taxes since 2022.
Best year ever: 2022, with € 846,774 profit.
Pays suppliers within 31 days on average.
A new publication or filing at INNOVATIVE MEDICAL SOLUTIONS HOLDING? We notify you, reason included.
Follow INNOVATIVE MEDICAL SOLUTIONS HOLDINGDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind INNOVATIVE MEDICAL SOLUTIONS HOLDING are Margaretha van den Broek and Bart de Bresser. The shares are held by Bart de Bresser (92.5%) and Peter Sillen (7.5%). It owns 200% of GymnaUniphy, 100% of Gymna France and 100% of Gymna Nederland BV itself.
Directors
According to the 2025 annual accounts
Margaretha van den Broek
Managing director
since 2020
since 2020
Shareholders
Bart de Bresser · director
92.5%
Peter Sillen
7.5%
Participations
Establishments
Establishment units
Physical locations of this company
Pasweg 6A
3740 Bilzen-Hoeselt
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0547.890.444
- VAT number
- BE 0547.890.444
- Registered office
- Pasweg 6A, 3740 Bilzen-Hoeselt
- Names & denominations
- INNOVATIVE MEDICAL SOLUTIONS HOLDING
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 12 March 2014
- Peppol
- Active · Active since 30 Jan 2025
- Activities · NACE
Activiteiten van holdings
Holdings
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
Adviesbureaus op het gebied van public relations en communicatie
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering